Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy E Marriott

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Proceedings of the National Academy of Sciences of the United States of America|April 4, 2022
<i>Wolbachia</i> depletion blocks transmission of lymphatic filariasis by preventing chitinase-dependent parasite exsheathmentShannon Quek, Darren A N Cook, Yang Wu, et al.
Thrombosis and Haemostasis|August 30, 2024
Handheld Point-of-Care Devices for Snakebite Coagulopathy: A Scoping ReviewMichael Abouyannis, Amy E Marriott, Emma Stars, et al.
BMJ Global Health|March 14, 2024
African polyvalent antivenom can maintain pharmacological stability and ability to neutralise murine venom lethality for decades post-expiry: evidence for increasing antivenom shelf life to aid in alleviating chronic shortagesGabriela Solano, Sinead Cunningham, Rebecca J Edge, et al.
Journal of Medicinal Chemistry|April 9, 2026
Identification of DC-174 as a Novel Hydroxamic Precandidate for the Development of an Oral Snakebite TreatmentDaniel J W Chong, Laura-Oana Albulescu, Adam Westhorpe, et al.
Science Translational Medicine|July 17, 2024
Molecular dissection of cobra venom highlights heparinoids as an antidote for spitting cobra envenomingTian Y Du, Steven R Hall, Felicity Chung, et al.
Frontiers in Microbiology|February 16, 2024
Combinations of the azaquinazoline anti-<i>Wolbachia</i> agent, AWZ1066S, with benzimidazole anthelmintics synergise to mediate sub-seven-day sterilising and curative efficacies in experimental models of filariasisShrilakshmi Hegde, Amy E Marriott, Nicolas Pionnier, et al.
ACS Infectious Diseases|April 2, 2021
Structural Requirements for Dihydrobenzoxazepinone Anthelmintics: Actions against Medically Important and Model Parasites: <i>Trichuris muris</i>, <i>Brugia malayi</i>, <i>Heligmosomoides polygyrus</i>, and <i>Schistosoma mansoni</i>Frederick A Partridge, Carole J R Bataille, Ruth Forman, et al.
Viruses|June 27, 2024
Sequential Infection with Influenza A Virus Followed by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Leads to More Severe Disease and Encephalitis in a Mouse Model of COVID-19Jordan J Clark, Rebekah Penrice-Randal, Parul Sharma, et al.
Nature|October 30, 2025
Nanobody-based recombinant antivenom for cobra, mamba and rinkhals bitesShirin Ahmadi, Nick J Burlet, Melisa Benard-Valle, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Proceedings of the National Academy of Sciences of the United States of America|April 4, 2022
<i>Wolbachia</i> depletion blocks transmission of lymphatic filariasis by preventing chitinase-dependent parasite exsheathmentShannon Quek, Darren A N Cook, Yang Wu, et al.
Thrombosis and Haemostasis|August 30, 2024
Handheld Point-of-Care Devices for Snakebite Coagulopathy: A Scoping ReviewMichael Abouyannis, Amy E Marriott, Emma Stars, et al.
BMJ Global Health|March 14, 2024
African polyvalent antivenom can maintain pharmacological stability and ability to neutralise murine venom lethality for decades post-expiry: evidence for increasing antivenom shelf life to aid in alleviating chronic shortagesGabriela Solano, Sinead Cunningham, Rebecca J Edge, et al.
Journal of Medicinal Chemistry|April 9, 2026
Identification of DC-174 as a Novel Hydroxamic Precandidate for the Development of an Oral Snakebite TreatmentDaniel J W Chong, Laura-Oana Albulescu, Adam Westhorpe, et al.
Science Translational Medicine|July 17, 2024
Molecular dissection of cobra venom highlights heparinoids as an antidote for spitting cobra envenomingTian Y Du, Steven R Hall, Felicity Chung, et al.
Frontiers in Microbiology|February 16, 2024
Combinations of the azaquinazoline anti-<i>Wolbachia</i> agent, AWZ1066S, with benzimidazole anthelmintics synergise to mediate sub-seven-day sterilising and curative efficacies in experimental models of filariasisShrilakshmi Hegde, Amy E Marriott, Nicolas Pionnier, et al.
ACS Infectious Diseases|April 2, 2021
Structural Requirements for Dihydrobenzoxazepinone Anthelmintics: Actions against Medically Important and Model Parasites: <i>Trichuris muris</i>, <i>Brugia malayi</i>, <i>Heligmosomoides polygyrus</i>, and <i>Schistosoma mansoni</i>Frederick A Partridge, Carole J R Bataille, Ruth Forman, et al.
Viruses|June 27, 2024
Sequential Infection with Influenza A Virus Followed by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Leads to More Severe Disease and Encephalitis in a Mouse Model of COVID-19Jordan J Clark, Rebekah Penrice-Randal, Parul Sharma, et al.
Nature|October 30, 2025
Nanobody-based recombinant antivenom for cobra, mamba and rinkhals bitesShirin Ahmadi, Nick J Burlet, Melisa Benard-Valle, et al.
Pageof 2